Traders sold shares of UnitedHealth Group Inc. (NYSE:UNH) on strength during trading hours on Friday. $76.06 million flowed into the stock on the tick-up and $145.86 million flowed out of the stock on the tick-down, for a money net flow of $69.80 million out of the stock. Of all stocks tracked, UnitedHealth Group had the 0th highest net out-flow for the day. UnitedHealth Group traded up $0.44 for the day and closed at $143.20

A number of research analysts have recently commented on the company. Oppenheimer Holdings Inc. reiterated an “outperform” rating and issued a $161.00 price target (up from $145.00) on shares of UnitedHealth Group in a research note on Friday, July 22nd. Citigroup Inc. increased their price target on UnitedHealth Group from $148.00 to $164.00 and gave the company a “buy” rating in a research note on Wednesday, July 20th. Barclays PLC increased their price target on UnitedHealth Group from $151.00 to $164.00 and gave the company an “overweight” rating in a research note on Wednesday, July 20th. Argus upgraded UnitedHealth Group from a “hold” rating to a “buy” rating and set a $170.00 price target for the company in a research note on Friday, July 22nd. Finally, Zacks Investment Research upgraded UnitedHealth Group from a “hold” rating to a “buy” rating and set a $160.00 price objective for the company in a report on Friday, July 22nd. One analyst has rated the stock with a hold rating, twenty-four have assigned a buy rating and one has given a strong buy rating to the company’s stock. The stock currently has an average rating of “Buy” and a consensus target price of $153.44.

The company has a 50-day moving average of $140.35 and a 200-day moving average of $128.80. The stock has a market cap of $138.47 billion and a PE ratio of 22.41.

UnitedHealth Group (NYSE:UNH) last announced its quarterly earnings results on Tuesday, July 19th. The healthcare conglomerate reported $1.96 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.89 by $0.07. The company had revenue of $46.50 billion for the quarter, compared to analysts’ expectations of $45.05 billion. Equities analysts forecast that UnitedHealth Group Inc. will post $7.91 earnings per share for the current year.

In other UnitedHealth Group news, Director Gail R. Wilensky sold 5,500 shares of the company’s stock in a transaction dated Friday, June 10th. The shares were sold at an average price of $139.80, for a total value of $768,900.00. Following the sale, the director now owns 59,019 shares in the company, valued at $8,250,856.20. The sale was disclosed in a filing with the SEC, which is available through the SEC website. Also, Director William C. Ballard, Jr. sold 5,000 shares of the company’s stock in a transaction dated Thursday, June 16th. The stock was sold at an average price of $138.58, for a total transaction of $692,900.00. Following the completion of the sale, the director now owns 72,229 shares in the company, valued at approximately $10,009,494.82. The disclosure for this sale can be found here.

A number of large investors have made changes to their positions in the company. Vanguard Group Inc. boosted its stake in shares of UnitedHealth Group by 1.8% in the fourth quarter. Vanguard Group Inc. now owns 54,496,944 shares of the healthcare conglomerate’s stock worth $6,411,021,000 after buying an additional 981,470 shares during the period. Wells Fargo & Company MN increased its position in shares of UnitedHealth Group by 12.0% in the fourth quarter. Wells Fargo & Company MN now owns 7,953,096 shares of the healthcare conglomerate’s stock valued at $935,602,000 after buying an additional 854,667 shares in the last quarter. Jennison Associates LLC increased its position in shares of UnitedHealth Group by 96.4% in the fourth quarter. Jennison Associates LLC now owns 785,534 shares of the healthcare conglomerate’s stock valued at $92,410,000 after buying an additional 385,632 shares in the last quarter. Marshall Wace LLP increased its position in shares of UnitedHealth Group by 224.0% in the fourth quarter. Marshall Wace LLP now owns 486,564 shares of the healthcare conglomerate’s stock valued at $57,240,000 after buying an additional 336,405 shares in the last quarter. Finally, Veritas Asset Management LLP increased its position in shares of UnitedHealth Group by 3.7% in the fourth quarter. Veritas Asset Management LLP now owns 4,921,507 shares of the healthcare conglomerate’s stock valued at $578,966,000 after buying an additional 175,899 shares in the last quarter.

UnitedHealth Group Incorporated is a diversified healthcare company. The Company operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight and OptumRx. The Company conducts its operations through two business platforms: health benefits operating under UnitedHealthcare and health services operating under Optum.

Get Analysts' Upgrades and Downgrades Daily - Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.